HPV 16 is one of many strains of human papillomavirus, a virus most sexually active people catch at some point. It is also the most cancer-causing strain, responsible for about half of cervical cancers worldwide.1Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases Catching it is not the same as getting cancer, since the large majority of infections disappear on their own. What makes HPV 16 dangerous is what it can do in the minority of people whose bodies don’t clear it.
What HPV 16 Actually Is
More than 40 types of HPV spread through sexual contact and infect the genitals, anus, mouth and throat.2American Society for Microbiology (Clinical Microbiology Reviews). Sexually transmitted human papillomavirus and related sequelae Low-risk types such as 6 and 11 cause genital warts but not cancer.3American Society for Microbiology (Clinical Microbiology Reviews). Sexually transmitted human papillomavirus and related sequelae High-risk HPV types, by contrast, can cause precancerous changes and cancers.4American Society for Microbiology (Clinical Microbiology Reviews). Sexually transmitted human papillomavirus and related sequelae HPV 16 and HPV 18 are the best-known of them.5Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases The link is strong: high-risk HPV is found in 99% of cervical precancers.6Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases
Together,7PubMed Central. HPV16 variants distribution in invasive cancers of the cervix, vulva, vagina, penis, and anus HPV 16 and 18 cause about two-thirds of cervical cancers worldwide.8Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases The virus is not a bystander here, because HPV infection is a necessary cause of cervical cancer.9PubMed. HPV in genital cancers (at the exception of cervical cancer) and anal cancers
HPV 16 spreads through skin-to-skin genital, anal and oral sexual contact, not only intercourse. Condoms lower the risk but don’t remove it, because the virus lives on skin they don’t cover. Most people never notice any symptoms, so partners usually can’t tell who passed it on. A positive result also doesn’t reveal when the infection began; it may date back years.
Unlike the low-risk types, HPV 16 rarely produces visible warts. Its precancerous changes are invisible and painless, which is why screening exists. Having no symptoms is normal and says nothing about whether the infection is clearing.
A positive result is not a sign that a partner cheated or that you did something wrong. The virus can sit undetected for years, so it may come from a relationship long past.
Why HPV 16 Can Turn Cells Cancerous
HPV has few genes of its own and depends on the host cell’s copying machinery to make more virus. The cells lining the skin and cervix have mostly stopped dividing, so the virus pushes them back into the copying phase. The cancer risk is a side effect: a cell forced to keep copying is a cell collecting mistakes.
The first tool is a protein called E6, which latches onto a cell’s own recycling machinery.10PubMed Central. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53 Together they tag p53, the protein that normally stops damaged cells from dividing, for destruction.11PubMed Central. Structure of the p53 degradation complex from HPV16 When DNA is damaged, p53 pauses the cell so repairs can happen, and if repair fails, it pushes the cell to self-destruct, removing a potential cancer seed. Without it, a cell with damaged DNA keeps dividing instead of repairing itself or dying, and the damage passes to its daughter cells.
A second protein, E7, binds pRb, a protein that holds cells back from copying their DNA.12PubMed Central. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb Cells are then pushed into nonstop DNA copying and division.13PubMed Central. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb
p53 and pRb are two separate brakes on cell growth, and HPV 16 cuts both. Even so, that alone doesn’t make cancer. Extra mistakes have to build up, and that takes years, which is why cancer typically appears long after infection, not within months.
The virus also hides. Early in infection HPV makes very little protein and keeps it inside the cell’s nucleus, so immune cells barely notice it.14PubMed Central. Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System E6 and E7 also block the alarm signals infected cells send to the immune system.15PubMed Central. Papillomavirus Immune Evasion Strategies Target the Infected Cell and the Local Immune System On top of that, some HPV 16 sub-strains carry much higher cancer risk than others, especially for a glandular form of cervical cancer.16PubMed Central. HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women
How Often HPV 16 Clears on Its Own
About 43% of HPV infections clear within 6 months, and up to 90% clear within 2 years.17PubMed Central. Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite The picture changes when an infection doesn’t clear. One that keeps showing up on repeat tests is called persistent.18PubMed Central. Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite In practice, persistence is judged by testing again after a gap, commonly a year or so, and finding the same high-risk type. That is why a doctor may suggest a repeat test rather than immediate treatment when cells look normal. Finding HPV 16 a second time moves it from wait-and-see to something that deserves a closer look.
Weakened immune systems, such as after an organ transplant or with HIV, make persistence more likely.19American Society for Microbiology (Clinical Microbiology Reviews). Sexually transmitted human papillomavirus and related sequelae Oral HPV 16 tends to persist more with age, likely as immune responses weaken.20PubMed Central. Long-term persistence of oral human papillomavirus type 16: The HPV Infection in Men (HIM) Study And when cells already look abnormal, only 35% to 53% of those changes go back to normal within 2 years.21PubMed Central. Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite
No pill or gel is proven to cure HPV; your immune system does the clearing. Not smoking is widely advised, since smoking is linked to HPV persisting. Managing HIV or other immune conditions with your doctor helps too. And keeping up with follow-up tests is what turns a persistent infection into a caught problem rather than a cancer.
A negative test later doesn’t always mean the virus is gone for good. It may be gone, or just too low to detect. If HPV 16 reappears, it can be a new infection or the old one becoming detectable again.
What Happens After a Positive HPV 16 Test
Modern screening tests check for high-risk HPV and name HPV 16 and 18 separately.22PubMed Central. Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology The reason is that HPV testing caught every case of moderate-or-worse precancer in one screening group, while the Pap smear caught about half.23PubMed Central. Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology So many guidelines send HPV 16-positive women to colposcopy, a magnified look at the cervix, even when the Pap result is normal.
A Pap smear looks at the shape of cells, while the HPV test looks for the virus itself. Changes caused by HPV 16 can exist before cells look abnormal under the microscope, or can be missed on a smear.
Colposcopy is the step between screening and treatment. Screening only says risk is higher; colposcopy checks whether abnormal cells are actually there. It feels like a longer Pap smear, with a lighted magnifier that stays outside the body. A vinegar solution is dabbed on so abnormal areas show up, and small biopsies may cause brief cramping. Results usually arrive in one to two weeks. The biopsy, not the HPV test alone, decides whether treatment is needed, and many people leave with a normal result and simply return for repeat testing later.
Reports may list CIN2 or CIN3, meaning moderate or severe precancerous changes, called CIN2+ together. CIN2 sometimes goes away by itself, so doctors may watch it in some people, particularly younger women. CIN3 is more likely to progress, so it is often treated with LEEP, a quick procedure that removes the abnormal area. Whether to treat or watch CIN2 depends on age, test results and plans, so it is fair to ask why a particular choice is recommended.
If HPV 16 is still present after LEEP, the chance of precancer returning is about 7 times higher.24PubMed Central. Correlation of the HPV 16 Genotype Persistence in Women Undergoing LEEP for CIN3 with the Risk of CIN2+ Relapses in the First 18 Months of Follow-Up: A Multicenter Retrospective Study Nearly all such returns happened within 2 years, and about 80% involved HPV 16.25PubMed Central. Correlation of the HPV 16 Genotype Persistence in Women Undergoing LEEP for CIN3 with the Risk of CIN2+ Relapses in the First 18 Months of Follow-Up: A Multicenter Retrospective Study Follow-up testing in those first two years matters most.
HPV 16 Beyond the Cervix
HPV 16 was found in 82% of cancers of the oropharynx, the back of the throat, tonsils and base of tongue.26PubMed. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma It was found in under 1% of head and neck cancers elsewhere.27PubMed. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma So HPV-linked mouth and throat cancer means the tonsil and tongue-base area specifically.
The tonsils and base of the tongue have deep folds in their lining that can hold the virus, unlike the flatter surfaces of the cheeks and gums. Smoking and heavy drinking remain the main causes of mouth cancers outside this area. HPV-linked throat cancers are often found because of a lump in the neck rather than throat pain.
Almost all anal cancers are caused by HPV.28PubMed Central. Human papillomavirus-associated anal cancer, vulvar verrucous cancer, and cervical cancer in a post-renal transplant patient-a case report HPV 16 accounts for about 80% of HPV-positive anal cancers.29PubMed. HPV in genital cancers (at the exception of cervical cancer) and anal cancers It is the most common type in vaginal, vulvar and penile cancers too, at around 60% in vaginal cancers.30PubMed. HPV in genital cancers (at the exception of cervical cancer) and anal cancers
Men have no routine HPV screening test. Their main HPV 16 risks are throat, anal and penile cancers. A sore throat, a lump in the neck or trouble swallowing that lasts for weeks deserves a doctor visit. Men who have sex with men or live with HIV may be offered anal cancer checks.
No test for oral HPV has been shown to reduce deaths from throat cancer, so none is recommended for the general public. Oral infection is common and mostly clears, so a positive test would worry many people who never develop cancer.
Long-term partners of someone with HPV 16 usually already share the virus by the time it’s found, so there is no reason to stop sex in a long relationship. Partners should keep their own screening and vaccination up to date.
How the HPV Vaccine Protects Against HPV 16
The vaccine contains empty virus shells made from a viral coat protein, with no viral DNA, so it cannot cause infection. The immune system learns to recognize the shell and makes antibodies that block the real virus before it enters cells. That is why it prevents new infection but does nothing to cells already infected.
In countries vaccinating at least half of girls, HPV 16 and 18 infections in teen girls fell by 68%.31PubMed Central. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis Genital warts fell by 61% in the same group.32PubMed Central. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis Related high-risk types also dropped, suggesting some extra protection.33PubMed Central. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis In the US, the share of precancers caused by HPV 16/18 among vaccinated women fell from about 54% to 28% in four years, but it barely changed in unvaccinated women.34PubMed Central. Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012 Countries with high coverage have seen cervical cancer itself decline.35PubMed Central. Impact of human papillomavirus vaccines in the reduction of infection, precursor lesions, and cervical cancer: A systematic literature review
Because it prevents infection rather than clearing it, the vaccine works best before any sexual exposure. It is routinely given to boys and girls around 11 to 12, when younger teens also tend to need fewer doses than older recipients. In the US it is recommended through age 26 and can be discussed with a doctor up to 45. Vaccinating boys protects them from throat, anal and penile cancers, not just their partners. Already having HPV 16 doesn’t make the vaccine useless, since it can protect against other types.
It does not treat an existing infection, and vaccinated women still need regular cervical screening. Common side effects are a sore arm and brief dizziness, not infertility.
Treatments on the Horizon
Researchers are testing vaccines that train the immune system to attack cells making E6 and E7.36PubMed Central. Current and future direction in treatment of HPV-related cervical disease Those proteins are good targets because only infected cells make them, so a vaccine aimed at them can single out those cells. HPV-caused cancer cells usually keep making them, since they depend on them to keep dividing.
Some of these vaccines have shown promising results in early human trials for precancer.37PubMed Central. Current and future direction in treatment of HPV-related cervical disease In mice, one shrank small tumors completely in most animals.38PubMed Central. A therapeutic multi-epitope protein vaccine targeting HPV16 E6 E7 elicits potent tumor regression and cytotoxic immune responses None is yet routine treatment, so current care remains screening and removal.
If you have persistent HPV 16 or recurring precancer, ask your doctor about clinical trials. Avoid products online that claim to cure HPV.